ACET - CIK 0001720580
The table below shows Adicet Bio, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $38.92M | $56.49M | $159.71M | $257.66M | $277.54M | $84.33M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $160.93M |
| $180.14M |
| $162.27M |
| $261.04M |
| $282.44M |
| $100.34M |
| Property, plant & equipment | $16.53M | $22.52M | $26.78M | $28.71M | $14.64M | $2.79M |
| Goodwill | - | - | $0.00 | $19.46M | $19.46M | $20.09M |
| Total assets | $192.35M | $220.22M | $207.29M | $330.69M | $338.94M | $153.84M |
| Accounts payable | $4.74M | $4.83M | $2.63M | $4.40M | $3.26M | $1.55M |
| Total current liabilities | $21.53M | $19.39M | $19.29M | $19.71M | $16.32M | $22.48M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $33.15M | $33.61M | $37.12M | $38.35M | $35.81M | $44.01M |
| Retained earnings | -$614.70M | -$497.89M | -$380.77M | -$238.11M | -$168.32M | -$106.33M |
| Total equity | $159.21M | $186.61M | $170.18M | $292.34M | $303.13M | $109.83M |